Clinical Trial Update: The Effect Of NS-0200 and NS-0300 Versus Placebo on Weight In Obesity [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating NS-0200 and NS-0300 versus placebo for weight loss in obesity; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NS-0200
• NS-0300

Snippet

Sponsor: NuSirt Biopharma | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2018-11-27